Achillion to Present at the 2018 JMP Securities Life Sciences Conference
June 14 2018 - 5:05AM
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN)
announced today that Joseph Truitt, President and Chief Executive
Officer of Achillion, will present at the 2018 JMP Securities Life
Sciences Conference on Thursday, June 21, 2018, at 9:00 a.m. ET at
the St. Regis New York Hotel, in New York, NY.
The live audio and subsequent archived webcasts
of the Company's presentations will be accessible from the
Company's investor relations website, http://ir.achillion.com. The
audio recording will be archived for 30 days following the live
presentation. Please connect to Achillion's website several minutes
prior to the start of the presentation to ensure adequate time for
any software downloads that may be necessary.
About Achillion
Pharmaceuticals
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is
a science-driven, patient-focused company seeking to leverage its
capabilities across the continuum from discovery to
commercialization in its goal of providing better treatments for
people with serious diseases. The company employs a
highly-disciplined discovery and development approach that has
allowed it to build a platform of potent and specific complement
factor D inhibitors for AP-mediated diseases. Achillion is rapidly
advancing its efforts to become a fully-integrated pharmaceutical
company with a goal of bringing life-saving medicines to patients
with rare diseases. More information is available
at http://www.achillion.com.
Investors & Media:Glenn
Schulman, PharmD, MPHAchillion Pharmaceuticals, Inc.Tel. (203)
752-5510gschulman@achillion.com
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Apr 2024 to May 2024
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Achillion Pharmaceuticals Inc (NASDAQ): 0 recent articles
More News Articles